FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2285807827> ?p ?o ?g. }

• W2285807827 endingPage "527" @default.
• W2285807827 startingPage "527" @default.
• W2285807827 abstract "Smoothened inhibitors (SIs) are a new type of targeted therapy for advanced basal cell carcinoma (BCC), and their long-term effects, such as increased risk of subsequent malignancy, are still being explored.To evaluate the risk of developing a non-BCC malignancy after SI exposure in patients with BCC.A case-control study at Stanford Medical Center, an academic hospital. Participants were higher-risk patients with BCC diagnosed from January 1, 1998, to December 31, 2014. The dates of the analysis were January 1 to November 1, 2015.The exposed participants (cases) comprised patients who had confirmed prior vismodegib treatment, and the nonexposed participants (controls) comprised patients who had never received any SI. Because vismodegib was the first approved SI, only patients exposed to this SI were included.Hazard ratio for non-BCC malignancies after vismodegib exposure, adjusting for covariates.The study cohort comprised 180 participants. Their mean (SD) age at BCC diagnosis was 56 (16) years, and 68.9% (n = 124) were male. Fifty-five cases were compared with 125 controls, accounting for age, sex, prior radiation therapy or cisplatin treatment, Charlson Comorbidity Index, clinical follow-up time, immunosuppression, and basal cell nevus syndrome status. Patients exposed to vismodegib had a hazard ratio of 6.37 (95% CI, 3.39-11.96; P < .001), indicating increased risk of developing a non-BCC malignancy. Most non-BCC malignancies were cutaneous squamous cell carcinomas, with a hazard ratio of 8.12 (95% CI, 3.89-16.97; P < .001), accounting for age and basal cell nevus syndrome status. There was no significant increase in other cancers.Increased risk for cutaneous squamous cell carcinomas after vismodegib therapy highlights the importance of continued skin surveillance after initiation of this therapy." @default.
• W2285807827 created "2016-06-24" @default.
• W2285807827 creator A5026764452 @default.
• W2285807827 creator A5040865719 @default.
• W2285807827 creator A5044978994 @default.
• W2285807827 creator A5056021087 @default.
• W2285807827 creator A5067600759 @default.
• W2285807827 creator A5075644312 @default.
• W2285807827 date "2016-05-01" @default.
• W2285807827 modified "2023-10-17" @default.
• W2285807827 title "Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma" @default.
• W2285807827 cites W1527808522 @default.
• W2285807827 cites W1728920319 @default.
• W2285807827 cites W1965431780 @default.
• W2285807827 cites W1996599316 @default.
• W2285807827 cites W2011359750 @default.
• W2285807827 cites W2031377991 @default.
• W2285807827 cites W2053000325 @default.
• W2285807827 cites W2053819584 @default.
• W2285807827 cites W2054657634 @default.
• W2285807827 cites W2055060118 @default.
• W2285807827 cites W2074686602 @default.
• W2285807827 cites W2084077080 @default.
• W2285807827 cites W2101616608 @default.
• W2285807827 cites W2102767758 @default.
• W2285807827 cites W2128736965 @default.
• W2285807827 cites W2137297899 @default.
• W2285807827 cites W2139499843 @default.
• W2285807827 cites W2143881980 @default.
• W2285807827 cites W2144535782 @default.
• W2285807827 cites W2161604940 @default.
• W2285807827 cites W2168591146 @default.
• W2285807827 cites W2169929967 @default.
• W2285807827 cites W2318044034 @default.
• W2285807827 cites W2417500563 @default.
• W2285807827 cites W2472582320 @default.
• W2285807827 doi "https://doi.org/10.1001/jamadermatol.2015.4330" @default.
• W2285807827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26914338" @default.
• W2285807827 hasPublicationYear "2016" @default.
• W2285807827 type Work @default.
• W2285807827 sameAs 2285807827 @default.
• W2285807827 citedByCount "91" @default.
• W2285807827 countsByYear W22858078272016 @default.
• W2285807827 countsByYear W22858078272017 @default.
• W2285807827 countsByYear W22858078272018 @default.
• W2285807827 countsByYear W22858078272019 @default.
• W2285807827 countsByYear W22858078272020 @default.
• W2285807827 countsByYear W22858078272021 @default.
• W2285807827 countsByYear W22858078272022 @default.
• W2285807827 countsByYear W22858078272023 @default.
• W2285807827 crossrefType "journal-article" @default.
• W2285807827 hasAuthorship W2285807827A5026764452 @default.
• W2285807827 hasAuthorship W2285807827A5040865719 @default.
• W2285807827 hasAuthorship W2285807827A5044978994 @default.
• W2285807827 hasAuthorship W2285807827A5056021087 @default.
• W2285807827 hasAuthorship W2285807827A5067600759 @default.
• W2285807827 hasAuthorship W2285807827A5075644312 @default.
• W2285807827 hasBestOaLocation W22858078271 @default.
• W2285807827 hasConcept C119060515 @default.
• W2285807827 hasConcept C121608353 @default.
• W2285807827 hasConcept C126322002 @default.
• W2285807827 hasConcept C143998085 @default.
• W2285807827 hasConcept C207103383 @default.
• W2285807827 hasConcept C2777789703 @default.
• W2285807827 hasConcept C2778804307 @default.
• W2285807827 hasConcept C2779399171 @default.
• W2285807827 hasConcept C2779545874 @default.
• W2285807827 hasConcept C3019992690 @default.
• W2285807827 hasConcept C44249647 @default.
• W2285807827 hasConcept C71924100 @default.
• W2285807827 hasConcept C72563966 @default.
• W2285807827 hasConceptScore W2285807827C119060515 @default.
• W2285807827 hasConceptScore W2285807827C121608353 @default.
• W2285807827 hasConceptScore W2285807827C126322002 @default.
• W2285807827 hasConceptScore W2285807827C143998085 @default.
• W2285807827 hasConceptScore W2285807827C207103383 @default.
• W2285807827 hasConceptScore W2285807827C2777789703 @default.
• W2285807827 hasConceptScore W2285807827C2778804307 @default.
• W2285807827 hasConceptScore W2285807827C2779399171 @default.
• W2285807827 hasConceptScore W2285807827C2779545874 @default.
• W2285807827 hasConceptScore W2285807827C3019992690 @default.
• W2285807827 hasConceptScore W2285807827C44249647 @default.
• W2285807827 hasConceptScore W2285807827C71924100 @default.
• W2285807827 hasConceptScore W2285807827C72563966 @default.
• W2285807827 hasIssue "5" @default.
• W2285807827 hasLocation W22858078271 @default.
• W2285807827 hasLocation W22858078272 @default.
• W2285807827 hasOpenAccess W2285807827 @default.
• W2285807827 hasPrimaryLocation W22858078271 @default.
• W2285807827 hasRelatedWork W1803222855 @default.
• W2285807827 hasRelatedWork W2071250613 @default.
• W2285807827 hasRelatedWork W2153743952 @default.
• W2285807827 hasRelatedWork W2607360241 @default.
• W2285807827 hasRelatedWork W2901949882 @default.
• W2285807827 hasRelatedWork W3045377858 @default.
• W2285807827 hasRelatedWork W3126292731 @default.
• W2285807827 hasRelatedWork W3196037314 @default.
• W2285807827 hasRelatedWork W4304804698 @default.

• next